Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (111-120 of 248) with videos related to

Pageof 25
Sort By:
British Journal of Cancer|March 24, 2017
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumourOlli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, et al.
European Journal of Medical Genetics|February 10, 2023
Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomasJulia Würtemberger, Tim Ripperger, Christian Vokuhl, et al.
Human Pathology|May 3, 2011
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumorsHans-Ulrich Schildhaus, Raffael Riegel, Wolfgang Hartmann, et al.
Anticancer Research|February 28, 2023
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell CarcinomaPascale Alicia Hoell, Khaled Elsayad, Hendrik Berssenbruegge, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapyLydia Lartigue, Agnès Neuville, Pauline Lagarde, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 7, 2018
AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short reportJan-Henrik Mikesch, Wolfgang Hartmann, Linus Angenendt, et al.
International Journal of Surgical Pathology|November 8, 2005
Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entityNicolaus Friedrichs, Maria Adele Testi, Luisa Moiraghi, et al.
Plos One|March 29, 2013
Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse modelKatharina König, Lydia Meder, Cornelia Kröger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)Sebastian Huss, Helen Künstlinger, Eva Wardelmann, et al.
Human Pathology|February 5, 2017
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare eventsSebastian Huss, Helen Pasternack, Michaela Angelika Ihle, et al.
Pageof 25

Showing results (111-120 of 248) with videos related to

Sort By:
Pageof 25
British Journal of Cancer|March 24, 2017
SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumourOlli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, et al.
European Journal of Medical Genetics|February 10, 2023
Genetic susceptibility in children, adolescents, and young adults diagnosed with soft-tissue sarcomasJulia Würtemberger, Tim Ripperger, Christian Vokuhl, et al.
Human Pathology|May 3, 2011
Lysine-specific demethylase 1 is highly expressed in solitary fibrous tumors, synovial sarcomas, rhabdomyosarcomas, desmoplastic small round cell tumors, and malignant peripheral nerve sheath tumorsHans-Ulrich Schildhaus, Raffael Riegel, Wolfgang Hartmann, et al.
Anticancer Research|February 28, 2023
Efficacy of Multimodality Approach in Patients With Recurrent Head and Neck Squamous Cell CarcinomaPascale Alicia Hoell, Khaled Elsayad, Hendrik Berssenbruegge, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2014
Genomic index predicts clinical outcome of intermediate-risk gastrointestinal stromal tumours, providing a new inclusion criterion for imatinib adjuvant therapyLydia Lartigue, Agnès Neuville, Pauline Lagarde, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 7, 2018
AAA+ ATPases Reptin and Pontin as potential diagnostic and prognostic biomarkers in salivary gland cancer - a short reportJan-Henrik Mikesch, Wolfgang Hartmann, Linus Angenendt, et al.
International Journal of Surgical Pathology|November 8, 2005
Clear cell sarcoma-like tumor with osteoclast-like giant cells in the small bowel: further evidence for a new tumor entityNicolaus Friedrichs, Maria Adele Testi, Luisa Moiraghi, et al.
Plos One|March 29, 2013
Loss of the keratin cytoskeleton is not sufficient to induce epithelial mesenchymal transition in a novel KRAS driven sporadic lung cancer mouse modelKatharina König, Lydia Meder, Cornelia Kröger, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 20, 2013
A subset of gastrointestinal stromal tumors previously regarded as wild-type tumors carries somatic activating mutations in KIT exon 8 (p.D419del)Sebastian Huss, Helen Künstlinger, Eva Wardelmann, et al.
Human Pathology|February 5, 2017
Clinicopathological and molecular features of a large cohort of gastrointestinal stromal tumors (GISTs) and review of the literature: BRAF mutations in KIT/PDGFRA wild-type GISTs are rare eventsSebastian Huss, Helen Pasternack, Michaela Angelika Ihle, et al.
Pageof 25